Amgen Inc. (AMGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN)

AMGN 337.68

-2.3%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.J.Smyth who wrote (579)	7/1/1998 8:35:00 PM
From: JohnP	Read Replies (2) of 1906

As a physician I have reviewed the products and recent approvals in AMGNs product line. I believe that AMGN could rise about 25%-50% in the next six months. This will be especially true if a large pharmaceutical company like Merck decides to buy AMGN. AMGN is unique among biotechs since it is has real products with real revenue, not just promises of drugs or cures several years down the road and perhaps seveal setbacks along the way. I am looking for AMGN to increase to about 75 - 80 by October. We'll see if I call this one right when that time comes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next